{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T04:50:24Z","timestamp":1696308624542},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Many studies have found that screening and treatment of latent tuberculosis (TB) before starting treatment with tumour necrosis factor (TNF)-\u03b1 inhibitors reduces associated TB infections. The new T-cell interferon-\u03b1 release assay (TIGRA), is more specific and sensitive for detection of latent TB compared with the tuberculin skin test (TST). We report results of TIGRA in our first 63 patients commencing TNF-\u03b1 inhibitors for severe psoriasis. Of the 63 patients, 5 (7.9%) had a positive TIGRA result and were started on treatment for latent TB. We found that the only risk factor for TB associated with a positive TIGRA was a history of travel to countries with high TB incidence. To our knowledge, this is the first study to identify the background risk (7.9%) of latent TB in an endemic UK population. This result emphasizes the importance of TIGRA testing to reduce the risk of TB in patients treated with TNF-\u03b1 inhibitor.<\/jats:p>","DOI":"10.1111\/j.1365-2230.2010.03850.x","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T16:53:31Z","timestamp":1272473611000},"page":"39-41","source":"Crossref","is-referenced-by-count":3,"title":["Clinical applicability of T-cell interferon-\u03b1 release assay for tumour necrosis factor-\u03b1 inhibitor therapy in severe psoriasis"],"prefix":"10.1093","volume":"36","author":[{"given":"Y. Z.","family":"Chiang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Panting","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dever","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A. G.","family":"Parslew","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"2023012703535367300_b1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2005.06893.x","article-title":"British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005","volume":"153","author":"Smith","year":"2005","journal-title":"Br J Dermatol"},{"key":"2023012703535367300_b2","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"2023012703535367300_b3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab \u2013 a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"2023012703535367300_b4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-\u03b1 treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"issue":"RR-11","key":"2023012703535367300_b5","first-page":"18","article-title":"Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the elimination of tuberculosis","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Recomm Rep"},{"key":"2023012703535367300_b6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2008.08891.x","article-title":"Tuberculosis and tumour necrosis factor-\u03b1 inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians","volume":"160","author":"Perlmutter","year":"2009","journal-title":"Br J Dermatol"},{"issue":"Suppl. I:II","key":"2023012703535367300_b7","first-page":"86","article-title":"Impact of screening for latent TB prior to initiation anti-TNF therapy in North America and Europe","volume":"64","author":"Perez","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2023012703535367300_b8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023012703535367300_b9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-\u03b3 assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"Lee","year":"2006","journal-title":"Eur Respir J"},{"key":"2023012703535367300_b10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","article-title":"Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients","volume":"28","author":"Piana","year":"2006","journal-title":"Eur Respir J"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2010.03850.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/36\/1\/39\/46911419\/ced0039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/36\/1\/39\/46911419\/ced0039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T04:05:52Z","timestamp":1674792352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/36\/1\/39\/6622177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,1]]},"published-print":{"date-parts":[[2011,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03850.x","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,1,1]]},"published":{"date-parts":[[2011,1,1]]}}}